Due to its implication in lung fibrogenesis, blockade of the TGFβ pathway has been proposed as a molecular strategy to ameliorate pulmonary fibrosis and is therefore of potential clinical significance [39]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.